Burden of virus-associated liver cancer in the Arab world, 1990-2010

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 1, 2015, Pages 265-270

  Khan, Gulfaraz ^a   Hashim, M Jawad ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Arabs; Cancer risk factors; Hepatitis B virus; Hepatitis C virus; Hepatocellular cancer

Indexed keywords

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHILD; COMPLICATION; CULTURAL ANTHROPOLOGY; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; MIDDLE EAST; MORTALITY; PATHOGENICITY; PRESCHOOL CHILD; RISK FACTOR; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARAB WORLD; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MIDDLE EAST; RISK FACTORS; YOUNG ADULT;

EID: 84924246810     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.1.265     Document Type: Article

References (33)

1. Altekruse SF, McGlynn KA, Reichman ME (2009). Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol, 27, 1485-91.
2. Arab League (2013). Arab countries figures and indicators. at .
3. Chang M-H, You S-L, Chen C-J, et al (2009). Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20- year follow-up study. J Natl Cancer Inst, 101, 1348-55.
4. Colombo M, Kuo G, Choo QL, et al (1989). Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet, 2, 1006-8.
5. Daw MA, Dau AA (2012). Hepatitis C virus in Arab world: a state of concern. ScientificWorld J, 2012, 719494.
6. Donato F, Tagger A, Gelatti U, et al (2002). Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol, 55, 323-31.
7. El-Serag HB, Rudolph KL (2007). Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132, 2557-76.
8. Frank C, Mohamed MK, Strickland GT, et al (2000). The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet, 355, 887-91.
9. Gasim GI (2013). Hepatitis B virus in the Arab world: where do we stand? Arab J Gastroenterol, 14, 35-43.
10. Gravitz L (2011). Introduction: a smouldering public-health crisis. Nature, 474, 2-4.
11. Howell J, Lemoine M, Thursz M (2014). Prevention of maternofoetal transmission of hepatitis B in sub-Saharan Africa: the evidence, current practice and future challenges. J Viral Hepat, 21, 381-96.
12. IHME (2013). Global burden of disease study 2010 (GBD 2010) Results by cause 1990-2010-country level. seattle, United States: institute for health metrics and evaluation (IHME). Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. Cancer J Clin, 61, 69-90.
13. Jemal A, Bray F, Forman D, et al (2012). Cancer burden in Africa and opportunities for prevention. Cancer, 118, 4372-84.
14. Kew MC, Houghton M, Choo QL, Kuo G (1990). Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet, 335, 873-4.
15. Liu J, Yang X-L, Li A, et al (2014). Epidemiological patterns of cancer incidence in southern China: based on 6 populationbased cancer registries. Asian Pac J Cancer Prev, 15, 1471-5.
16. Lozano R, Naghavi M, Foreman K, et al (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global burden of disease study 2010. Lancet, 380, 2095-128.
17. Luo Z, Li L, Ruan B (2012). Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period. Int J Infect Dis, 16, 82-8.
18. Mokdad AH, Jaber S, Aziz MIA, et al (2014). The state of health in the Arab world, 1990-2010: an analysis of the burden of diseases, injuries, and risk factors. Lancet, 383, 309-20.
19. Morgan TR, Mandayam S, Jamal MM (2004). Alcohol and hepatocellular carcinoma. Gastroenterology, 127, 87-96.
20. Murray CJL, Ezzati M, Flaxman AD, et al (2012). GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology. Lancet, 380, 2055-8.
21. Murray CJL, Ezzati M, Flaxman AD, et al (2012). GBD 2010: design, definitions, and metrics. Lancet, 380, 2063-6.
22. Murray CJL, Vos T, Lozano R, et al (2012). Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2197-223.
23. Pileri P, Uematsu Y, Campagnoli S, et al (1998). Binding of hepatitis C virus to CD81. Science, 282, 938-41.
24. Ploss A, Evans MJ, Gaysinskaya VA, et al (2009). Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature, 457, 882-6.
25. Rahim HFA, Sibai A, Khader Y, et al (2014). Non-communicable diseases in the Arab world. Lancet, 383, 356-67.
26. Ray S, Bailey J, Thomas D (2013). Hepatitis C Virus. In: Knipe DM, Howley PM, eds. Fields Virology, 1, 795-824.
27. Razavi H, Waked I, Sarrazin C, et al (2014). The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat, 21, 34-59.
28. Salim EI, Moore MA, Al-Lawati JA, Al-Sayyad J, et al (2009). Cancer epidemiology and control in the Arab world - past, present and future. Asian Pac J Cancer Prev, 10, 3-16.
29. Seeger C, Zoulim F, Mason W (2013). Hepadnaviruses. In: Knipe DM, Howley PM, eds. Fields Virology, 2, 2185-221.
30. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP (2006). Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev, 28, 112-25.
31. Wang H, Dwyer-Lindgren L, Lofgren KT, et al (2012). Agespecific and sex-specific mortality in 187 countries, 1970- 2010: a systematic analysis for the global burden of disease study 2010. Lancet, 380, 2071-94.
32. WHO (WHO: 2013). Global policy report on the prevention and control of viral hepatitis.
33. Yeo Y, Gwack J, Kang S, et al (2013). Viral hepatitis and liver cancer in Korea: an epidemiological perspective. Asian Pac J Cancer Prev, 14, 6227-31.